Premium
Ischaemic stroke
Author(s) -
Meschia J. F.,
Brott T.
Publication year - 2018
Publication title -
european journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.881
H-Index - 124
eISSN - 1468-1331
pISSN - 1351-5101
DOI - 10.1111/ene.13409
Subject(s) - medicine , stroke (engine) , ischaemic stroke , atrial fibrillation , hyperlipidemia , acute stroke , smoking cessation , physical therapy , intensive care medicine , cardiology , diabetes mellitus , pathology , tissue plasminogen activator , mechanical engineering , engineering , endocrinology
There are about 25.7 million stroke survivors worldwide. Ischaemic stroke remains the most common type of stroke. Numerous modifiable risk factors have been identified, including behaviors such as cigarette smoking and sedentary lifestyle and treatable medical comorbidities such as hypertension, hyperlipidemia and atrial fibrillation. Once considered irreversible, acute ischaemic stroke is now amenable to acute medical and endovascular therapies to reduce infarct volume. Many advances are expected in the years to come, particularly in the areas of prevention and recovery.